After Disappointing Data, Imara Offloads It Sickle Cell Candidate, Shares Surge
08 Sep 2022 //
YAHOO
Imara flunks a pair of phase 2bs, wiping out clinical pipeline
06 Apr 2022 //
MEDCITY NEWS
FDA Clears Imara`s IND for Tovinontrine in HFpEF
25 Jan 2022 //
GLOBENEWSWIRE